Dr. Britt Kristina Erickson, MD

Dr. Erickson practices at M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview.

Dr. Erickson's NPI, 1225294762, was assigned on August 4, 2008. Dr. Erickson graduated from Mayo Clinic Alix School of Medicine - Rochester in 2008. Dr. Erickson holds Minnesota license 59686.

Dr. Erickson's primary practice is M Health Fairview University of Minnesota Medical Center, at 2450 Riverside Avenue, Minneapolis, MN 55454 in Hennepin County. The practice phone is (612) 624-1765.

Dr. Erickson's primary practice is M Health Fairview University of Minnesota Medical Center in Minneapolis, Minnesota, part of M Health Fairview. Dr. Erickson is also affiliated with M Health Fairview Southdale Hospital. The medical group on file is M Health Fairview Recovery Clinic. Dmand AI also links Dr. Erickson to 4 more medical groups, 3 group practices and clinics and 1 dialysis center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erickson practices, 6 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Erickson's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Erickson is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Erickson's licenses on file in 4 states: Minnesota, Wisconsin, Alabama and Illinois.

Dmand AI lists hysterectomy and ovarian cyst among the conditions Dr. Erickson treats.

CMS data shows 53 Medicare services from Dr. Erickson across 2 procedure codes in 2024, all of them office visits, for 37 Medicare patients. Medicare paid $5,122 for them. Every service was in an office.

CMS counts 37 Medicare patients who saw Dr. Erickson in 2024. The largest group is 65 to 74, with 22 patients. 75% of them have high blood pressure, and 54% have high cholesterol. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erickson's median patient age at 62, with 100% women.

In 2024, Dr. Erickson wrote 95 Medicare Part D claims for 39 patients. 89% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $535 in total drug cost. In 2023, CMS named 80 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Erickson for performance year 2024, reported as part of a group. Dr. Erickson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Erickson as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 77 papers to Dr. Erickson, published from 2011 to 2025. 2024 was the busiest year, with 6. The most frequent topics are Ovarian Neoplasms, Uterine Cervical Neoplasms and Biomarkers, Tumor. Dr. Erickson has published most often in Gynecol Oncol. Dr. Erickson's most frequent co-authors are Warner K. Huh, MD, Charles A. Leath and Ronald D. Alvarez, MD.

Dmand AI links Dr. Erickson to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms, Ovarian Diseases and Endometrial Hyperplasia.

CMS Open Payments shows 25 general payments to Dr. Erickson from 13 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 95% of the total. Merck Sharp & Dohme Corporation paid the most, $5,185.

Dr. Erickson graduated from Mayo Clinic Alix School of Medicine - Rochester in 2008.

Dr. Erickson is in network with 15 carriers, including Aetna, United Healthcare and Medica. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.